AstraZeneca PLC (AZNN) — Cash Flow-to-Debt Ratio
AstraZeneca PLC (AZNN) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of MX$2.34 Billion could theoretically repay 0% of its total liabilities (MX$65.36 Billion) in one year. See AstraZeneca PLC (AZNN) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AstraZeneca PLC Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for AstraZeneca PLC across 12 annual periods. For the full cash flow conversion analysis, see AstraZeneca PLC operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for AstraZeneca PLC (2014–2025)
Year-by-year debt coverage analysis for AstraZeneca PLC. Check cash flow quality index of AstraZeneca PLC to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (MXN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | MX$14.57 Billion | MX$65.36 Billion | ▲ +18.8% |
| 2024 | 0.19x | MX$11.86 Billion | MX$63.16 Billion | ▲ +12.3% |
| 2023 | 0.17x | MX$10.36 Billion | MX$61.95 Billion | ▲ +1.3% |
| 2022 | 0.17x | MX$9.81 Billion | MX$59.42 Billion | ▲ +82.9% |
| 2021 | 0.09x | MX$5.96 Billion | MX$66.08 Billion | ▼ -3.9% |
| 2020 | 0.09x | MX$4.80 Billion | MX$51.09 Billion | ▲ +48.0% |
| 2019 | 0.06x | MX$2.97 Billion | MX$46.78 Billion | ▲ +13.0% |
| 2018 | 0.06x | MX$2.62 Billion | MX$46.61 Billion | ▼ -26.7% |
| 2017 | 0.08x | MX$3.58 Billion | MX$46.71 Billion | ▼ -15.3% |
| 2016 | 0.09x | MX$4.14 Billion | MX$45.86 Billion | ▲ +13.0% |
| 2015 | 0.08x | MX$3.32 Billion | MX$41.55 Billion | ▼ -55.8% |
| 2014 | 0.18x | MX$7.06 Billion | MX$38.95 Billion | — |